Stephen E. Sterrett
Known title: DirectorCIK: 0001235739
Stephen E. Sterrett's purchase track record
Stephen E. Sterrett has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/19/2025 | AMCR | $86K | -0.8% | +16.2% | +6.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| EQR | ▲ Buy | Grant | 3,276 | $0 | 6/18/2026 | View on chart |
| AMCR | ▲ Buy | Option Exercise | 9,317 | — | 12/2/2025 | View on chart |
| AMCR | ▲ Buy | Option Exercise | 29,319 | $0 | 11/22/2025 | View on chart |
| AMCR | ▲ Buy | Open Market | 10,000 | $86K | 8/19/2025 | View on chart |
| EQR | ▲ Buy | Grant | 1,852 | $100K | 8/14/2025 | View on chart |
| EQR | ▲ Buy | Grant | 3,122 | $0 | 7/1/2025 | View on chart |
| AMCR | ▲ Buy | Grant | 358,091 | — | 4/30/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Amcor compared to other dividend stocks in recent articles
Recent financial articles have compared Amcor against Realty Income, Clorox, and other S&P 500 names, focusing on dividend yields and safety. These comparisons highlight Amcor's 5.34% dividend yield as a key factor for income-focused readers. The stock is currently trading near its 52-week high, with an average analyst target of $49.76.
Amcor compared to other dividend stocks in recent articles. Recent financial articles have compared Amcor against Realty Income, Clorox, and other S&P 500 names, focusing on dividend yields and safety. These comparisons highlight Amcor's 5.34% dividend yield as a key factor for income-focused readers. The stock is currently trading near its 52-week high, with an average analyst target of $49.76.